Medical Injection Articles
-
Understanding Lumbar Spinal Stenosis with Neurogenic Claudication
What is Lumbar Spinal Stenosis? Lumbar spinal stenosis, or LSS, is a common condition in which the lower spinal canal narrows and compresses the nerves in the lower back. Lumbar spinal stenosis is generally caused by aging and natural wear and tear on the spine. With lumbar spinal stenosis, thickened ligament, overgrowth of bone, and/or bulging discs in the lower back put pressure on the ...
-
Rani is Opening Doors in Biosimilars, Challenging Humira and Others
San Jose-based Rani Therapeutics reported its fourth quarter and full-year 2021 financial results, as well as several corporate updates. The company hit major milestones this year, including the recent launch of the RaniPill High Capacity, which opens doors for significant developments in biosimilars. Rani has been on the radar of major life science investors for years. The company caught ...
-
Rani developing technology for oral delivery of injectable biologics
(NASDAQ:RANI) is developing a disruptive technology to solve the problem of converting biologic injectable drugs, including antibodies, peptides and proteins, into oral therapies with its RaniPill that bypasses destruction in the stomach to deliver its payload to the vascular intestinal wall in the GI tract. “This is not a new idea, although previous attempts were based on chemistry and ...
-
Raising Awareness on the Challenges of Injections: `My First Injection`
Twelve years ago Jody started getting unexplained pain, swelling and redness in her eyes after having her first child. Shortly after, she was diagnosed with Scleritis¹, a serious eye disease that is often associated with an underlying autoimmune disorder. Fast forward to today, Jody has started taking weekly injections to ease her symptoms. We sat down with Jody to hear ...
-
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday. According to S-1 filings, shares were estimated to price between $14 and $16 last week. On Friday, shares debuted slightly lower, around $11. Rani raised about $73 million in its debut. Rani’s debut comes amidst a flurry of IPO activity in therapeutics. In 2020, 71 ...
-
Meco`s Masterfit System Selected for Nexus Pharmaceutical Facility
Introduction “Our priority is to provide our customers with the high purity water and steam that is critical to the development and manufacturing of life-saving medications now and for future generations.” —George Gsell, MECO President Nexus Pharmaceuticals, maker of difficult-to-manufacture, high quality, FDA-approved specialty and generic drugs, is opening a $250 million, ...
-
Brentwood Donates 5,000 Face Shields to Penn State Health St. Joseph
Brentwood is proud to partner with Penn State Health St. Joseph in Berks County’s fight against COVID-19. The company donated 5,000 reusable face shields to the hospital to protect healthcare workers as the pandemic continues. Brentwood President, Peter Rye, and his wife, Leigh, presented the donation to hospital representatives on Wednesday. “We wanted to protect those working to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you